Konica Minolta Medical Imaging announced that its parent company, Konica Minolta, Inc., has signed a business transfer agreement with Panasonic Healthcare Co., Ltd. (Panasonic Healthcare) under which the ultrasonic diagnostic equipment business of Panasonic Healthcare is to be transferred to Konica Minolta. All Panasonic Healthcare's assets necessary for planning, development, manufacturing, sales, maintenance, etc., will be transferred, effective on January 1, 2014.

The procedure, first performed in Germany in 2011, has corrected both defects and instilled Brian, a young swimmer and martial arts aficionado, with newfound energy that was in short supply earlier this year.
With increased penalties in effect for hospitals with excessive readmissions for heart attack and heart failure, the American College of Cardiology (ACC) is launching a program that applies a team approach to keeping patients at home and healthy after discharge.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Konica Minolta Medical Imaging announced the launch of the Sonimage P3 hand-held ultrasound device. The Sonimage P3 brings advanced imaging capabilities to the patient or bedside.

GE Healthcare announced at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago that its U.S. Food and Drug Administration (FDA) 510(k)-pending Revolution CT 256-slice system has captured a motion-free image of the human heart in just one beat.
Siemens Healthcare introduced an angiography system optimized for broad clinical utilization at the Radiological Society of North America Annual Meeting (RSNA 2013).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

HeartWare International Inc. has acquired CircuLite, Inc., a developer of the Synergy Circulatory Support System, which is designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent.

Over the past decade, medical imaging has gone from being one of the fastest growing categories of Medicare spending to one of the slowest relative to other Medicare services, according to a new study.

Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its flexible 4 French multi-electrode Symplicity Spyral catheter and Symplicity G3 radio frequency (RF) generator.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running randomized, controlled clinical trial of renal denervation, which continue to demonstrate results consistent with data reported previously at six, 12 and 24-months of follow-up. The data were presented for the first time during an oral abstract session on Tuesday, October 29, 2013 at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium taking place this week in San Francisco. The Symplicity renal denervation system is available for investigational use only in the United States.

A national group of leading scientists, including one University of Alabama at Birmingham (UAB) expert, said that for more than 100 years, fewer people have been dying of stroke, yet it is still unclear why this decline remains constant.
Sidra Medical and Research Center, a specialty women's and children's hospital in Qatar, announced that Ziyad Hijazi, M.D., has been appointed clinical chief for pediatrics.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Merge Healthcare is showcasing its new universal viewer solution at Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.

The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation: mitral valve repair and mitral valve replacement.

Four cardiovascular professional societies released an overview of transcatheter therapies for mitral regurgitation. Intended to “help frame subsequent discussions” among the field’s various stakeholders, the document highlights critical issues that should be considered as the technologies are integrated into clinical practice.